ロード中...
Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrinology Research Centre
2018-12-01
|
| シリーズ: | Ожирение и метаболизм |
| 主題: | |
| オンライン･アクセス: | https://www.omet-endojournals.ru/jour/article/view/9584 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|